NYMX News and Press, Nymox Pharmaceutical Corporation From 01/29/19

We at White Diamond Research like shorting medical device companies with an inefficient product or products. Last year, we exposed Transenterix ( TRXC ) and Viveve Systems ( VIVE ) as each has a medical device that is fundamentally flawed. Our next medical device stock short idea is Heli...

HASBROUCK HEIGHTS, N.J., July 02, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced today that following the recently announced increased manufacturing capabilities, the Company has formally decided to expand its European marketing plans for Fexapotide Triflu...

Gainers : XRM +100% . XBIO +96% . YECO +69% . ABIL +66% . TSRI +33% . LGCYO +32% . ATV +31% . CADC +20% . LGCYP +18% . VLRX +17% . More news on: Xerium Technologies, Inc., Xenetic Biosciences, Inc., Yulong Eco-Materials, Stocks on the move, , Read more ....

Thinly traded micro cap Nymox Pharmaceutical ( NYMX +4.2% ) announces that it has achieved manufacturing scale-up milestones for lead drug fexapotide triflutate, increasing both batch size and yield. More news on: Nymox Pharmaceutical Corporation, Healthcare stocks news, Stocks on the ...

HASBROUCK HEIGHTS, N.J., June 07, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to report that manufacturing scale-up milestones have been reached for the Company's lead compound Fexapotide Triflutate (FT). Over the past year, the Company has worked...